XBiotech Inc (XBIT)

24.30 -0.59  -2.39% NASDAQ Jan 17, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
05/08/2020 Earnings XBiotech Inc First Quarter Earnings Results in 2020
11/12/2019 Earnings XBiotech Inc Third Quarter Earnings Results for 2019
08/09/2019 Earnings XBiotech Inc Second Quarter Earnings Results in 2019
06/19/2019 Misc XBiotech Inc Annual General Meeting in 2018
05/09/2019 Earnings XBiotech Inc First Quarter Earnings in 2019 Release
03/15/2019 Misc XBiotech Inc Annual Report in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.xbiotech.com
  • Investor Relations URL: http://www.xbiotech.com/about/investors.html
  • HQ State/Province: Texas
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: May. 08, 2020
  • Last Earnings Release: Nov. 12, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: XBiotech Inc is an US based clinical-stage biopharmaceutical company which is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing MABp1 a therapeutic antibody as a treatment for cancer. It has developed therapeutic antibody Xilonix which is being evaluated as a monotherapy to treat advanced stages of colorectal cancer. Xilonix neutralizes a pro-inflammatory protein produced by leukocytes and other cells.

Top Fund Holders

Symbol Name Weighting
BBC Virtus LifeSci Biotech Clinical Trls ETF 1.19%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.